Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × brigatinib × 30 days × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 21 Surveys and Questionnaires 19 Specimen Handling 11 Radiotherapy 9 Immune Checkpoint Inhibitors 8 Watchful Waiting 7 Observation 6 Interviews as Topic 6 Biopsy 6 Drug Therapy 5 ribociclib 4 Tissue Banks 4 pembrolizumab 3 lenvatinib 3 enzalutamide 3 darolutamide 3 Standard of Care 3 Magnetic Resonance Spectroscopy 3 Liquid Biopsy 3 Letrozole 3 Anastrozole 3 trametinib 2 regorafenib 2 pertuzumab 2 efgartigimod alfa 2 durvalumab 2 dabrafenib 2 atezolizumab 2 apalutamide 2 Tomography, X-Ray Computed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05721950 2026-02-18

Brilliant

Takeda

Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡